Market Watch: GoodRx Holdings Inc (GDRX)’s Noteworthy Drop, Closing at 4.91

Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.

As of close of business last night, GoodRx Holdings Inc’s stock clocked out at $4.91, down -3.16% from its previous closing price of $5.07. In other words, the price has decreased by -$3.16 from its previous closing price. On the day, 2.05 million shares were traded.

Ratios:

To gain a deeper understanding of GDRX’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 5.83 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 11.71. For the most recent quarter (mrq), Quick Ratio is recorded 5.23 and its Current Ratio is at 5.23. In the meantime, Its Debt-to-Equity ratio is 0.83 whereas as Long-Term Debt/Eq ratio is at 0.81.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Mizuho on December 04, 2024, initiated with a Neutral rating and assigned the stock a target price of $5.

On August 09, 2024, Raymond James Upgraded its rating to Strong Buy which previously was Outperform but kept the price unchanged to $10.

RBC Capital Mkts Upgraded its Sector Perform to Outperform on May 23, 2024, whereas the target price for the stock was revised from $8 to $10.

Insider Transactions:

Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Jun 06 ’25 when Spectrum Equity VII, L.P. sold 10,677 shares for $4.09 per share. The transaction valued at 43,706 led to the insider holds 0 shares of the business.

Spectrum VII Investment Manage bought 6,828 shares of GDRX for $27,312 on Jun 06 ’25. On Jun 06 ’25, another insider, Spectrum VII Co-Investment Fun, who serves as the Affiliate of the company, bought 3,849 shares for $4.00 each.

Valuation Measures:

As of this moment, GoodRx’s Price-to-Earnings (P/E) ratio for their current fiscal year is 66.08, and their Forward P/E ratio for the next fiscal year is 10.70. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 4.50. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.20 while its Price-to-Book (P/B) ratio in mrq is 2.71.

Stock Price History:

Over the past 52 weeks, GDRX has reached a high of $9.26, while it has fallen to a 52-week low of $3.67. The 50-Day Moving Average of the stock is 13.90%, while the 200-Day Moving Average is calculated to be -2.90%.

Shares Statistics:

A total of 103.94M shares are outstanding, with a floating share count of 83.18M. Insiders hold about 76.71% of the company’s shares, while institutions hold 16.03% stake in the company.

Leave a Reply

Your email address will not be published. Required fields are marked *

DWinneX
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.